Role of anthraquinones in combating insulin resistance

Insulin resistance presents a formidable public health challenge that is intricately linked to the onset and progression of various chronic ailments, including diabetes, cardiovascular disease, hypertension, metabolic syndrome, nonalcoholic fatty liver disease, and cancer. Effectively addressing ins...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 14; p. 1275430
Main Authors Xia, Wanru, Li, Shuqian, Li, LinZehao, Zhang, Shibo, Wang, Xiaolei, Ding, Wenyu, Ding, Lina, Zhang, Xiandang, Wang, Zhibin
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 20.11.2023
Subjects
anthraquinones
antiinflammation
insulin resistance
intestinal microbiome
natural products
Pharmacology
natural products
antiinflammation
anthraquinones
insulin resistance
intestinal microbiome
Online AccessGet full text

Cover

More Information
Summary:Insulin resistance presents a formidable public health challenge that is intricately linked to the onset and progression of various chronic ailments, including diabetes, cardiovascular disease, hypertension, metabolic syndrome, nonalcoholic fatty liver disease, and cancer. Effectively addressing insulin resistance is paramount in preventing and managing these metabolic disorders. Natural herbal remedies show promise in combating insulin resistance, with anthraquinone extracts garnering attention for their role in enhancing insulin sensitivity and treating diabetes. Anthraquinones are believed to ameliorate insulin resistance through diverse pathways, encompassing activation of the AMP-activated protein kinase (AMPK) signaling pathway, restoration of insulin signal transduction, attenuation of inflammatory pathways, and modulation of gut microbiota. This comprehensive review aims to consolidate the potential anthraquinone compounds that exert beneficial effects on insulin resistance, elucidating the underlying mechanisms responsible for their therapeutic impact. The evidence discussed in this review points toward the potential utilization of anthraquinones as a promising therapeutic strategy to combat insulin resistance and its associated metabolic diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Yasmina Esther Hernández-Santana, APC, Ireland
Reviewed by: Jia-Wen Shou, The Chinese University of Hong Kong, China
Edited by: Abd El-Latif Hesham, Beni-Suef University, Egypt
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2023.1275430